Synthesis of enantlopure 2-Aryl(Alkyl)-2-trIfluoromethyl-substituted morpholines and oxazepanes

European Journal of Organic Chemistry

Volumn , Issue 22, 2009, Pages 3726-3731

  Nonnenmacher, Jean ^a   Grellepois, Fabienne ^a   Portella, Charles ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Asymmetric synthesis; Cyclization; Enantiopurity; Fluorine; Heterocycles

Indexed keywords

EID: 67650689320     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.200900387     Document Type: Article

References (26)

1. a) J. P. Bégué, D. Bonnet-Delpon, Bioorganic and Medicinal Chemistry of Fluorine, Wiley-VCH, Weinheim, 2008;
2. b) S. Purser, P. R. Moore, S. Swallow, V. Gouvemeur, Chem. Soc. Rev. 2008, 37, 320-330;
3. c) K. L. Kirk, Org. Process Res. Dev. 2008, 12, 305-321;
4. d) W. K. Hagmann, J. Med Chem. 2008, 57, 4359-4369.
5. D. Letnicer, Organic Chemistry of Drug Synthesis, vol. 7, Wiley, New York, 2008.
6. S. Kamashima, T. Matsuno S. Yaguchi, T. Watanabe, M. Inaba, PCT Int. Appl., WO 9905138, 1999.
7. M. R. Barbachyn, P. J. Dobrowolski, A. R. Hurd, D. J. McNa-mara, J. R. Palmer, A. G. Romero, J. C. Ruble, D. A. Sherry, L. M. Thomasco, P. L. Toogood, PCT Int. Appl., WO 2004031195, 2004.
8. C. Luethy, A. Edmunds, R. Beaudegnies, S. Wendeborn, J. Schaetzer, W. Lutz, PCT Int. Appl. WO 2005058830, 2005.
9. K. Fukunaga, T. Kohara, K. Watanabe, Y. Usui, F. Uehara, S. Yokoshima, D. Sakai, S. Kusaka, K. Nakayama, PCT Int. Appl., WO 2007119463, 2007.
10. a) L. ElKaïm, E. Pinot-Périgord, Tetrahedron 1998, 54, 3799-3806;
11. b) M. W Walter. N. Thaker, J. E. Baldwin. M. Muller. C. J. Schofield, J. Chem. Res. (S) 2000, 7, 310-311;
12. c) M. H. Serrano-Wu, D. R. StLaurent, T. M. Carroll, M. Dodier, Q. Gao, P. Gill, C. Quesnelle, A. Marinier, C. E. Mazzucco, A. Regueiro-Ren, T. M. Stickle, D. Wu, H. Yang, Z. Zandg, M. Zheng, M. E. Zoeckler, D. M. Vyas, B. N. Balasubramanian, Bioorg. Med. Chem. Lett. 2003, 13, 1419-1423;
13. d) S. Fustero, L. Albert, J. L. Acena, J. F. Sanz-Cervera, A. Asensio, Org. Lett. 2008, 10, 605-608.
14. a) P. H. Liang. L, W. Hsin, C. Y. Cheng, Bioorg. Med. Chem. 2002, 10, 3267-3276;
15. b) M. Eberle. H. Ziegler, F. Cederbaum. P. Ackermann, PCT Int. Appl., WO 2002053560, 2002;
16. c) G. Chaume, M. C. VanSeveren, S. Marinkovic, T. Brigaud, Org. Lett. 2006, 8, 6123-6126;
17. d) C. Caupene, G. Chaume, L. Ricard, T. Brigaud, Org. Lett. 2009, 11, 209-212.
18. J. Nonnenmacher, F. Massicot, F. Grellepois. C. Portella, J. Org. Chem. 2008, 73, 7990-7995.
19. 3, see: A. F. Abdel-Magid, S. J. Mehrman, Org. Process Res. Dev. 2006, 10, 971-1031.
20. For reviews on iodocyclisation, see for example: a) G. Cardillo, M. Orena. Tetrahedron 1990, 46, 3321-3408;
21. b) H. Xogo. S. Ida, Synlett 2006, 2159-2175.
22. CCDC-726924 contains the supplementary crystallographic data for this paper. Xhese data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data-request/cif.
23. The inversion of the configuration of C5 reflects only the change in priority of substituents at this stereocentre.
24. S. Ram, L. D. Spicer, Tetrahedron Lett. 1987, 28, 515-516.
25. For a review, see: J. Wipf, H. Jahn, Tetrahedron 1996, 52, 12853-12910.
26. M. Ahari, A. Joosten, J. L. Vasse, J. Szymoniak, Synthesis 2008, 1, 61-68.